UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 76

Sortiert nach

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

Blood, 2012-02, Vol.119 (6), p.1599-1606

2012

Volltextzugriff (PDF)

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

JAMA : the journal of the American Medical Association, 2011-11, Vol.306 (17), p.1874

2011

Volltextzugriff (PDF)

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

Critical care (London, England), 2008-01, Vol.12 (3), p.R83-R83

2008

Volltextzugriff (PDF)

A non‐fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2013-05, Vol.121 (5), p.456-459

2013

Volltextzugriff (PDF)

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Haematologica (Roma), 2014-10, Vol.99 (10), p.1624

2014

Volltextzugriff (PDF)

Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma

European journal of haematology, 2012-08, Vol.89 (2), p.151-159

2012

Volltextzugriff (PDF)

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

European journal of haematology, 2001-02, Vol.66 (2), p.73-82

Vindelov, Lars

2001

Volltextzugriff (PDF)

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (12), p.1556-1560

2016

Volltextzugriff (PDF)

Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2002-02, Vol.110 (2), p.148-157

2002

Volltextzugriff (PDF)

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Blood, 2014-12, Vol.124 (21), p.1176-1176

2014

Volltextzugriff (PDF)

Identification and HLA-tetramer-validation of human [CD4.sup.+] and [CD8.sup.+] T cell responses against HCMV proteins IE1 and IE2

PloS one, 2014-04, Vol.9 (4)

2014

Volltextzugriff (PDF)

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT

Blood, 2012-11, Vol.120 (21), p.3098-3098

2012

Volltextzugriff (PDF)

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

American journal of hematology, 2008-07, Vol.83 (7), p.563-569

2008

Volltextzugriff (PDF)

Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage

Cancer research (Chicago, Ill.), 1990-06, Vol.50 (11), p.3311-3316

1990

Volltextzugriff (PDF)

Impact of Chronic Graft-Versus-Host disease (GVHD) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) As Treatment for Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of the EBMT

Blood, 2011-11, Vol.118 (21), p.321-321

2011

Volltextzugriff (PDF)

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II

Cancer research (Chicago, Ill.), 1991-10, Vol.51 (19), p.5093-5099

1991

Volltextzugriff (PDF)

Haematopoietic stem cell transplantation with non‐myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution

British journal of haematology, 2004-04, Vol.125 (2), p.225-231

2004

Volltextzugriff (PDF)

Association of HMGB1 Polymorphisms with Outcome After Allogeneic Hematopoietic Cell Transplantation

Blood, 2009-11, Vol.114 (22), p.2260-2260

2009

Volltextzugriff (PDF)

Genetic Variation in AKAP13 Is Associated with Increased Risk of Relapse after Allogeneic Hematopoietic Cell Transplantation Following Non-Myeloablative Conditioning

Blood, 2008-11, Vol.112 (11), p.3257-3257

2008

Volltextzugriff (PDF)

The PTPN22 1858C/T Polymorphism Is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning

Blood, 2007-11, Vol.110 (11), p.1969-1969

2007

Volltextzugriff (PDF)

A Randomized Trial Comparing Busulfan With Total Body Irradiation as Conditioning in Allogeneic Marrow Transplant Recipients With Leukemia: A Report From the Nordic Bone Marrow Transplantation Group

Blood, 1994-05, Vol.83 (9), p.2723-2730

1994

Volltextzugriff (PDF)

1 – 25 von 76

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(45)
Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Biological And Medical Sciences
(25)
Medical Sciences
(24)
Flow Cytometry
(20)
Animals
(19)
Male
(18)
Female
(17)
Mice
(16)
Middle Aged
(15)
Hematology
(12)
Mice, Nude
(12)
Neoplasm Transplantation
(11)
Adult
(10)
Aged
(10)
Antineoplastic Agents
(10)
Carcinoma, Small Cell - Drug Therapy
(10)
Lung Neoplasms - Drug Therapy
(10)
Oncology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome

A non‐fatal case of invasive zygomycete (Lichtheimia corymbifera) infection in an allogeneic haematopoietic cell transplant recipient

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma

Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT)

Reduced intensity conditioning is superior to nonmyeloablative conditioning for older chronic myelogenous leukemia patients undergoing hematopoietic cell transplant during the tyrosine kinase inhibitor era

YKL-40 in allogeneic hematopoietic cell transplantation after acute myeloid leukemia and myelodysplastic syndrome

Generation of EBV-specific CTLs suitable for adoptive immunotherapy of EBV-associated lymphoproliferative disease following allogeneic transplantation

The Prognostic Value of YKL-40 in Allogeneic Hematopoietic Cell Transplantation

Identification and HLA-tetramer-validation of human [CD4.sup.+] and [CD8.sup.+] T cell responses against HCMV proteins IE1 and IE2

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT

Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning

Equivalent Outcome Between Older Siblings and Unrelated Donors After Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in First Complete Remission: A Report From the ALWP of EBMT

Mobilized peripheral blood stem cells compared with bone marrow from HLA-identical siblings for reduced-intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT

Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4'-(9-acridylamino)methanesulfon-m-anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage

Impact of Chronic Graft-Versus-Host disease (GVHD) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) As Treatment for Acute Myeloid Leukemia (AML): A Survey From the Acute Leukemia Working Party of the EBMT

Antagonistic effect of aclarubicin on daunorubicin-induced cytotoxicity in human small cell lung cancer cells: relationship to DNA integrity and topoisomerase II

Haematopoietic stem cell transplantation with non‐myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution

Association of HMGB1 Polymorphisms with Outcome After Allogeneic Hematopoietic Cell Transplantation

Genetic Variation in AKAP13 Is Associated with Increased Risk of Relapse after Allogeneic Hematopoietic Cell Transplantation Following Non-Myeloablative Conditioning

The PTPN22 1858C/T Polymorphism Is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning

A Randomized Trial Comparing Busulfan With Total Body Irradiation as Conditioning in Allogeneic Marrow Transplant Recipients With Leukemia: A Report From the Nordic Bone Marrow Transplantation Group

Aktive Filter

Suchergebnisse filtern